Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen

ClinicalTrials.gov ID: NCT00035633

Public ClinicalTrials.gov record NCT00035633. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00035633
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Entecavir Drug

Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2001
Primary completion
Jan 31, 2005
Completion
Jan 31, 2005
Last update posted
Apr 13, 2011

2001 – 2005

United States locations

U.S. sites
35
U.S. states
21
U.S. cities
32
Facility City State ZIP Site status
Local Investigator Birmingham Alabama 35294
Local Investigator Tucson Arizona 85724
Local Investigator La Jolla California 92037
Local Investigator Los Angeles California 90048
Local Investigator Orange California 92868
Local Investigator Palo Alto California 94304
Local Institution San Francisco California 94115
Local Investigator Torrance California 90505
Local Investigator Farmington Connecticut 06030
Local Investigator Miami Florida 33136
Local Investigator Atlanta Georgia 30309
Local Investigator Atlanta Georgia 30322
Local Investigator Honolulu Hawaii 96820
Local Investigator Chicago Illinois 60622
Local Investigator Iowa City Iowa 52242
Local Investigator Boston Massachusetts 02111
Local Investigator Worcester Massachusetts 01655
Local Investigator Ann Arbor Michigan 48109
Local Investigator Royal Oak Michigan 48073
Local Investigator Saint Paul Minnesota 55114
Local Investigator Manhasset New York 11030
Local Investigator New York New York 10003
Local Investigator New York New York 10029
Local Investigator New York New York 10032
Local Investigator Rochester New York 14642
Local Investigator Charlotte North Carolina 28203
Local Investigator Cleveland Ohio 44125
Local Investigator Philadelphia Pennsylvania 19104
Local Investigator Pittsburgh Pennsylvania 15213
Investigator Meeting Providence Rhode Island 02908
Local Investigator Nashville Tennessee 37211
Local Investigator Dallas Texas 75235
Local Investigator Fairfax Virginia 22031
Local Investigator Richmond Virginia 23249
Local Investigator Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00035633, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2011 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00035633 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →